Login / Signup

Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.

Nabih MaslahSalome RetyMelina BonnamyLorea AguinagaTony HuynhVeronique PariettiStephane GiraudierPierre FenauxBruno Cassinat
Published in: Leukemia (2024)
Keyphrases
  • acute myeloid leukemia
  • induced apoptosis
  • cell cycle arrest
  • oxidative stress
  • acute lymphoblastic leukemia
  • cell proliferation
  • wild type